Occudo Quantitative Strategies LP Glaukos Corp Transaction History
Occudo Quantitative Strategies LP
- $500 Million
- Q4 2024
A detailed history of Occudo Quantitative Strategies LP transactions in Glaukos Corp stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 2,420 shares of GKOS stock, worth $233,965. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,420
Previous 4,237
42.88%
Holding current value
$233,965
Previous $551,000
34.3%
% of portfolio
0.07%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
346Shares Held
47.9MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$777 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$578 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$199 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$187 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$141 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.6B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...